For those of us who have been in the field for decades, this cycle of exhilaration or despair is common and manageable, but recent months have raised even further uncertainty about how progress in ...

A team of researchers explain how navigation programs work, who benefits, and how to create a successful navigation program.

Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08. Operator: Good day and thank you for ...

So, how can the hurdles to continued healthcare provider (HCP) and patient adoption be overcome in this saturated ... with their limited apps. Whilst standard PaaS (platform as a service ...

Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat ...

The Gazette will host a series of free, virtual panel discussions this week aimed at exploring Iowa's cancer rates, the ...

“With FDA approval due in 2019, it appears that Keytruda/Inlyta will and should become a new standard of care for the renal cancer patient population after posting this trial data.” The combo ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

The success of AI in healthcare is influenced more by human factors and organizational readiness than by the technology ...

Q1 2025 Earnings Call Transcript May 13, 2025 Exelixis, Inc. beats earnings expectations. Reported EPS is $0.55, expectations ...

Yahoo Sports senior NBA reporter Vincent Goodwill spoke to the 3-time NBA champion and Hall of Famer about the Minnesota ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...